基本信息
-
人胰高血糖素样肽-1
-
106612-94-6
-
7-37-Glucagon-like peptide I (human); Insulinotropin (human); Peptide GLP-1 (human glucose-lowering peptide-1)
-
C151H228N40O47
-
3355.67
-
7-37-Glucagon-likepeptide I (human)
-
-
1.48±0.1 g/cm3(Predicted)
-
Glucagon-relatedpeptide 1 (Rana catesbeiana), 3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-;10: PN: US20080299096 SEQID: 9 unclaimed sequence; 10: PN: WO03103572 SEQID: 16unclaimed protein; 10: PN: WO2008150821 SEQID: 9 unclaimed protein; 111: PN:WO0198331 TABLE: 1 claimed protein; 116: PN: WO2007124463 SEQID: 1 claimedsequence; 11: PN: EP1972349 SEQID: 1 unclaimed sequence; 11: PN: US6284725SEQID: 3 unclaimed protein; 11: PN: WO0066138 PAGE: 11 unclaimed protein; 11:PN: WO0136643 FIGURE: 4 unclaimed protein; 11: PN: WO2008101017 SEQID: 50unclaimed sequence; 137: PN: WO2006074600 SEQID: 2 unclaimed sequence; 13: PN:WO2004056313 SEQID: 11 unclaimed sequence; 14: PN: WO2005097175 SEQID: 15claimed protein; 15: PN: WO2007076319 SEQID: 15 claimed protein; 15: PN:WO2007081302 SEQID: 15 claimed sequence; 17: PN: WO0039278 SEQID: 23 unclaimedprotein; 18: PN: WO2004022004 SEQID: 2 claimed sequence; 18: PN: WO2007062531SEQID: 18 unclaimed sequence; 19: PN: WO02072605 SEQID: 19 unclaimed protein;1: PN: CN101463081 SEQID: 1 claimed protein; 1: PN: CN1982336 SEQID: 1unclaimed sequence; 1: PN: US20040143104 SEQID: 21 unclaimed sequence; 1: PN:US20060286129 SEQID: 1 claimed sequence; 1: PN: WO0155213 SEQID: 1 claimedprotein; 1: PN: WO03014318 SEQID: 21 claimed protein; 1: PN: WO2004093823SEQID: 1 claimed protein; 1: PN: WO2005019262 SEQID: 1 claimed protein; 1: PN:WO2005027978 SEQID: 1 unclaimed protein; 1: PN: WO2005028516 SEQID: 1 claimedprotein; 1: PN: WO2006126673 SEQID: 1 claimed protein; 1: PN: WO2007049695SEQID: 2 claimed sequence; 1: PN: WO2008097504 PAGE: 42 unclaimed sequence; 1:PN: WO2008132477 PAGE: 5 unclaimed sequence; 1: PN: WO2009020802 SEQID: 3unclaimed sequence; 1: PN: WO2009035540 SEQID: 3 unclaimed sequence; 1: PN:WO2009067268 PAGE: 9 unclaimed sequence; 1: PN: WO2009080032 SEQID: 1 unclaimedsequence; 1: PN: WO2009083549 SEQID: 1 unclaimed sequence;
-
-
-
-
详细信息
杭州专肽生物(www.allpeptide.com)一直致力于、专注于修饰多肽的合成及研发,目前已经在很多方面取得了突破,并获得定制多肽行业的认可。 各类修饰让多肽的结构丰富起来,可以在多肽的N端、C端、活性侧链基团(羧基、氨基、羟基、酚羟基、巯基等)进行改造或形成各类环肽。同时多肽修饰让多肽的运用更加广泛起来,几乎所有的生物研究领域都有涉及到多肽,包括比较热门的肿瘤领域、生物材料领域,核磁共振领域等。
各类糖肽
各类荧光标记肽(Fam、FITC、TAMRRA、CY等)
含有DOTA、NOTA、DTPA等放射性螯合物前体多肽
众多羧基化合物和氨基化合物修饰的肽段
引入叠氮、炔基、烯基结构的肽段及点击化学运用
小分子、大分子PEG修饰
环肽(如酰胺、二硫键、硫酯、硫醚键、脲基成环)
引入叠氮、炔基、烯基结构的肽段及点击化学运用
同位素标记肽
环二肽
KLH和BSA蛋白载体多肽
R8S81订书肽
Dansyl和EDANS双标记肽
磷酸化肽磺酸化肽
甲基化肽
MAPs多聚抗原肽
醛肽
CMK、AMC、pNA